Genomics, Diabetes and Endocrinology
1 – 10 of 1066
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Activation of imidazoline receptor I2, and improved pancreatic β-cell function in human islets
- Haplotype Sharing Provides Insights into Fine-Scale Population History and Disease in Finland
- Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement
- Treatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016
- One-hour glucose value as a long-term predictor of cardiovascular morbidity and mortality : the Malmö Preventive Project
- Turning vice into virtue : Using Batch-Effects to Detect Errors in Large Genomic Datasets
- Depression in type 1 diabetes was associated with high levels of circulating galectin-3
- Genome-wide meta-analysis identifies novel determinants of circulating serum progranulin
- Glutamine-elicited secretion of glucagon-like peptide 1 is governed by an activated glutamate dehydrogenase
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas